|Articles|January 23, 2023
At-line Spent Media Analysis using the REBEL to Optimize a CHO mAb Fed-Batch Process
Author(s)908 Devices
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5